Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7(1):47. https://doi.org/10.1038/s41572-021-00280-3
Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, Na DL (2010) Seoul neuropsychological screening battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci 25(7):1071–1076. https://doi.org/10.3346/jkms.2010.25.7.1071
Article PubMed PubMed Central Google Scholar
Baik K, Kim HR, Park M, Lee Y, Na HK, Sohn YH, Seong JK, Lee PH (2023) Effect of amyloid on cognitive performance in parkinson’s disease and dementia with lewy bodies. Mov Disord 38(2):278–285. https://doi.org/10.1002/mds.29295
Article CAS PubMed Google Scholar
Bastiaanse R, Leenders KL (2009) Language and parkinson’s disease. Cortex 45(8):912–914. https://doi.org/10.1016/j.cortex.2009.03.011
Betrouni N, Devignes Q, Bayot M, Derambure P, Defebvre L, Leentjens AF, Delval A, Dujardin K (2022) The frontostriatal subtype of mild cognitive impairment in parkinson’s disease, but not the posterior cortical one, is associated with specific EEG alterations. Cortex 153:166–177. https://doi.org/10.1016/j.cortex.2022.04.015
Bocanegra Y, García AM, Pineda D, Buriticá O, Villegas A, Lopera F, Gómez D, Gómez-Arias C, Cardona JF, Trujillo N, Ibáñez A (2015) Syntax, action verbs, action semantics, and object semantics in parkinson’s disease: dissociability, progression, and executive influences. Cortex 69:237–254. https://doi.org/10.1016/j.cortex.2015.05.022
Brenner RP, Ulrich RF, Reynolds CF (1995) EEG spectral findings in healthy, elderly men and women–sex differences. Electroencephalogr Clin Neurophysiol 94(1):1–5. https://doi.org/10.1016/0013-4694(94)00234-c
Article CAS PubMed Google Scholar
Caviness JN, Utianski RL, Hentz JG, Beach TG, Dugger BN, Shill HA, Driver-Dunckley ED, Sabbagh MN, Mehta S, Adler CH (2016) Differential spectral quantitative electroencephalography patterns between control and parkinson’s disease cohorts. Eur J Neurol 23(2):387–392. https://doi.org/10.1111/ene.12878
Article CAS PubMed Google Scholar
Cholerton BA, Zabetian CP, Wan JY, Montine TJ, Quinn JF, Mata IF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Leverenz JB, Edwards KL (2014) Evaluation of mild cognitive impairment subtypes in Parkinson’s disease. Mov Disord 29(6):756–764. https://doi.org/10.1002/mds.25875
Article PubMed PubMed Central Google Scholar
Chung SJ, Park YH, Yun HJ, Kwon H, Yoo HS, Sohn YH, Lee JM, Lee PH (2019) Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson’s disease. Eur J Neurol 26(5):766–773. https://doi.org/10.1111/ene.13886
Article CAS PubMed Google Scholar
Chung SJ, Lee HS, Kim HR, Yoo HS, Lee YH, Jung JH, Baik K, Ye BS, Sohn YH, Lee PH (2020) Factor analysis-derived cognitive profile predicting early dementia conversion in PD. Neurology 95(12):e1650–e1659. https://doi.org/10.1212/wnl.0000000000010347
Article CAS PubMed Google Scholar
De Pablo-Fernández E, Lees AJ, Holton JL, Warner TT (2019) Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease. JAMA Neurol 76(4):470–479. https://doi.org/10.1001/jamaneurol.2018.4377
Article PubMed PubMed Central Google Scholar
Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22(12):1689–1707. https://doi.org/10.1002/mds.21507
Ferreira D, Przybelski SA, Lesnick TG, Lemstra AW, Londos E, Blanc F, Nedelska Z, Schwarz CG, Graff-Radford J, Senjem ML, Fields JA, Knopman DS, Savica R, Ferman TJ, Graff-Radford NR, Lowe VJ, Jack CR Jr., Petersen RC, Mollenhauer B, Garcia-Ptacek S, Abdelnour C, Hort J, Bonanni L, Oppedal K, Kramberger MG, Boeve BF, Aarsland D, Westman E, Kantarci K (2020) β-amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies. Neurology 95(24):e3257–e3268. https://doi.org/10.1212/wnl.0000000000010943
Geraedts VJ, Boon LI, Marinus J, Gouw AA, van Hilten JJ, Stam CJ, Tannemaat MR, Contarino MF (2018) Clinical correlates of quantitative EEG in Parkinson disease: a systematic review. Neurology 91(19):871–883. https://doi.org/10.1212/wnl.0000000000006473
Goldman JG, Weis H, Stebbins G, Bernard B, Goetz CG (2012) Clinical differences among mild cognitive impairment subtypes in Parkinson’s disease. Mov Disord 27(9):1129–1136. https://doi.org/10.1002/mds.25062
Article PubMed PubMed Central Google Scholar
Goldman JG, Aggarwal NT, Schroeder CD (2015) Mild cognitive impairment: an update in Parkinson’s disease and lessons learned from Alzheimer’s disease. Neurodegener Dis Manag 5(5):425–443. https://doi.org/10.2217/nmt.15.34
Article PubMed PubMed Central Google Scholar
Goldman JG, Holden SK, Litvan I, McKeith I, Stebbins GT, Taylor JP (2018) Evolution of diagnostic criteria and assessments for Parkinson’s disease mild cognitive impairment. Mov Disord 33(4):503–510. https://doi.org/10.1002/mds.27323
Article PubMed PubMed Central Google Scholar
Han C, Cheung VCK, Chan RHM (2025) Aging amplifies sex differences in low alpha and low beta EEG oscillations. Neuroimage 312:121231. https://doi.org/10.1016/j.neuroimage.2025.121231
Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837–844. https://doi.org/10.1002/mds.21956
Hobson P, Meara J (2004) Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in the United Kingdom. Mov Disord 19(9):1043–1049. https://doi.org/10.1002/mds.20216
Hoogland J, Boel JA, de Bie RM, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI (2017) Mild cognitive impairment as a risk factor for Parkinson’s disease dementia. Mov Disord 32(7):1056–1065
Hughes TA, Read L, Mindham RH (1998) Neuropsychological prediction of dementia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 65(5):804–805. https://doi.org/10.1136/jnnp.65.5.804
Article CAS PubMed PubMed Central Google Scholar
Kalbe E, Rehberg SP, Heber I, Kronenbuerger M, Schulz JB, Storch A, Linse K, Schneider C, Gräber S, Liepelt-Scarfone I, Berg D, Dams J, Balzer-Geldsetzer M, Hilker R, Oberschmidt C, Witt K, Schmidt N, Mollenhauer B, Trenkwalder C, Spottke A, Roeske S, Wittchen HU, Riedel O, Dodel R (2016) Subtypes of mild cognitive impairment in patients with Parkinson’s disease: evidence from the LANDSCAPE study. J Neurol Neurosurg Psychiatry 87(10):1099–1105. https://doi.org/10.1136/jnnp-2016-313838
Kim S, Choi SH, Lee YM, Kim MJ, Kim YD, Kim JY, Park JH, Myung W, Na HR, Han HJ, Shim YS, Kim JH, Yoon SJ, Kim SY, Kim DK (2015) Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study. Int Psychogeriatr 27(12):2069–2077. https://doi.org/10.1017/s1041610215001076
Levy G, Jacobs DM, Tang MX, Côté LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K (2002a) Memory and executive function impairment predict dementia in Parkinson’s disease. Mov Disord 17(6):1221–1226. https://doi.org/10.1002/mds.10280
Levy G, Tang MX, Louis ED, Côté LJ, Alfaro B, Mejia H, Stern Y, Marder K (2002b) The association of incident dementia with mortality in PD. Neurology 59(11):1708–1713. https://doi.org/10.1212/01.wnl.0000036610.36834.e0
Article CAS PubMed Google Scholar
Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in parkinson’s disease: movement disorder society task force guidelines. Mov Disord 27(3):349–356. https://doi.org/10.1002/mds.24893
Article PubMed PubMed Central Google Scholar
Liu L, Luo XG, Dy CL, Ren Y, Feng Y, Yu HM, Shang H, He ZY (2015) Characteristics of language impairment in Parkinson’s disease and its influencing factors. Transl Neurodegener 4(1):2. https://doi.org/10.1186/2047-9158-4-2
Comments (0)